1. Except as limited by subsection 2, “dispense” means to deliver a controlled substance to an ultimate user, patient or research subject by or pursuant to the lawful order of a practitioner, including the prescribing, administering, packaging, labeling or compounding necessary to prepare the substance for that delivery.
2. The term does not include the furnishing of a controlled substance by a hospital pharmacy for inpatients.
(Added to NRS by 1971, 2000; A 1973, 579; 1977, 672, 938; 1979, 1654; 1987, 1653; 1991, 1648)